Moreover, glucose intolerance and insulin resistance caused by diabetes were ameliorated by CFP and liraglutide as assessed by OGTT, ITT, and HOMA-IR index, and the effect tended to be stronger in liraglutide-treated group (Figures 1F–H). The gene discussed is CFP; the disease is Glucose intolerance.